Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe study has been terminated as per the sponsor's decision, and the results have been posted with a new version revision. The previous recruiting status and submission date have been removed.SummaryDifference3%
- Check36 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check79 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check94 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check101 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.